Component
10-Gingerol
Experimental species, exposure and limitations are retained on each claim.
8 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
10-Gingerol did not displace GR65630 from the human 5-HT3 receptor preparation.
Experimental context and source evidence
- dose
- Gingerols with tritiated GR65630; exact concentration range not in accessed abstract
- duration
- Equilibrium assay; duration not specified in accessed abstract
- evidence_access
- Primary PubMed abstract.
- evidence_scope
- literature_reviewed; model-specific source-derived curation, not universally established human effects
- experimental_model
- Human 5-HT3 receptors in HEK293 membrane preparations
- limitations
- Failure to displace this radioligand supports a distinct mechanism but does not locate an allosteric site.
- nutrient_topic
- Gingerols collection; each molecular form and experimental preparation remains explicit. · Gingerols
- organism
- Human 5-HT3 receptors in HEK293 membrane preparations
- plain_language
- 10-Gingerol did not displace GR65630 from the human 5-HT3 receptor preparation.
- primary_references
- Mode of action of gingerols and shogaols on 5-HT3 receptors: binding studies, cation uptake by the receptor channel and contraction of isolated guinea-pig ileum. (2006). https://pubmed.ncbi.nlm.nih.gov/16364290/ DOI: 10.1016/j.ejphar.2005.10.049
- route
- In vitro competition binding
- tissue
- Receptor preparation
Gingerols: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 129–138
Original AI-assisted curation of thirteen primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · Human 5-HT3 receptors in HEK293 membrane preparations · source_derived_draft · unverified_draft
## gingerols-10-5ht3-binding-null 10-Gingerol did not displace GR65630 from the human 5-HT3 receptor preparation. Model/species: Human 5-HT3 receptors in HEK293 membrane preparations Tissue: Receptor preparation Exposure: Gingerols with tritiated GR65630; exact concentration range not in accessed abstract Route: In vitro competition binding Duration: Equilibrium assay; duration not specified in accessed abstract Limits: Failure to displace this radioligand supports a distinct mechanism but does not locate an allosteric site. Primary reference: Mode of action of gingerols and shogaols on 5-HT3 receptors: binding studies, cation uptake by the receptor channel and contraction of isolated guinea-pig ileum. (2006). https://pubmed.ncbi.nlm.nih.gov/16364290/ DOI: 10.1016/j.ejphar.2005.10.049 Access: Primary PubMed abstract.
Complete structured claim and evidence10-Gingerol inhibited 5-HT3-mediated cation influx in N1E-115 cells.
Experimental context and source evidence
- dose
- Concentration-dependent gingerol application; exact range not in accessed abstract
- duration
- Not specified in accessed abstract
- evidence_access
- Primary PubMed abstract.
- evidence_scope
- literature_reviewed; model-specific source-derived curation, not universally established human effects
- experimental_model
- Mouse N1E-115 neuroblastoma cells
- limitations
- Cation flux is a functional assay, not a demonstrated orthosteric binding site or clinical antiemetic response.
- nutrient_topic
- Gingerols collection; each molecular form and experimental preparation remains explicit. · Gingerols
- organism
- Mouse N1E-115 neuroblastoma cells
- plain_language
- 10-Gingerol inhibited 5-HT3-mediated cation influx in N1E-115 cells.
- primary_references
- Mode of action of gingerols and shogaols on 5-HT3 receptors: binding studies, cation uptake by the receptor channel and contraction of isolated guinea-pig ileum. (2006). https://pubmed.ncbi.nlm.nih.gov/16364290/ DOI: 10.1016/j.ejphar.2005.10.049
- route
- In vitro addition
- tissue
- Native 5-HT3 receptor-channel complex
Gingerols: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 118–127
Original AI-assisted curation of thirteen primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · Mouse N1E-115 neuroblastoma cells · source_derived_draft · unverified_draft
## gingerols-10-5ht3-flux 10-Gingerol inhibited 5-HT3-mediated cation influx in N1E-115 cells. Model/species: Mouse N1E-115 neuroblastoma cells Tissue: Native 5-HT3 receptor-channel complex Exposure: Concentration-dependent gingerol application; exact range not in accessed abstract Route: In vitro addition Duration: Not specified in accessed abstract Limits: Cation flux is a functional assay, not a demonstrated orthosteric binding site or clinical antiemetic response. Primary reference: Mode of action of gingerols and shogaols on 5-HT3 receptors: binding studies, cation uptake by the receptor channel and contraction of isolated guinea-pig ileum. (2006). https://pubmed.ncbi.nlm.nih.gov/16364290/ DOI: 10.1016/j.ejphar.2005.10.049 Access: Primary PubMed abstract.
Complete structured claim and evidence10-Gingerol reduced contractions elicited by the selective 5-HT3 agonist in isolated guinea-pig ileum.
Experimental context and source evidence
- dose
- Gingerols with selective 5-HT3 agonist SR57227A; exact range not in accessed abstract
- duration
- Not specified in accessed abstract
- evidence_access
- Primary PubMed abstract.
- evidence_scope
- literature_reviewed; model-specific source-derived curation, not universally established human effects
- experimental_model
- Isolated guinea-pig ileum
- limitations
- Muscarinic and substance-P-dependent downstream effects may contribute; no human antiemetic efficacy is measured.
- nutrient_topic
- Gingerols collection; each molecular form and experimental preparation remains explicit. · Gingerols
- organism
- Isolated guinea-pig ileum
- plain_language
- 10-Gingerol reduced contractions elicited by the selective 5-HT3 agonist in isolated guinea-pig ileum.
- primary_references
- Mode of action of gingerols and shogaols on 5-HT3 receptors: binding studies, cation uptake by the receptor channel and contraction of isolated guinea-pig ileum. (2006). https://pubmed.ncbi.nlm.nih.gov/16364290/ DOI: 10.1016/j.ejphar.2005.10.049
- route
- Ex vivo addition
- tissue
- Intestinal smooth muscle preparation
Gingerols: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 140–149
Original AI-assisted curation of thirteen primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · Isolated guinea-pig ileum · source_derived_draft · unverified_draft
## gingerols-10-ileum 10-Gingerol reduced contractions elicited by the selective 5-HT3 agonist in isolated guinea-pig ileum. Model/species: Isolated guinea-pig ileum Tissue: Intestinal smooth muscle preparation Exposure: Gingerols with selective 5-HT3 agonist SR57227A; exact range not in accessed abstract Route: Ex vivo addition Duration: Not specified in accessed abstract Limits: Muscarinic and substance-P-dependent downstream effects may contribute; no human antiemetic efficacy is measured. Primary reference: Mode of action of gingerols and shogaols on 5-HT3 receptors: binding studies, cation uptake by the receptor channel and contraction of isolated guinea-pig ileum. (2006). https://pubmed.ncbi.nlm.nih.gov/16364290/ DOI: 10.1016/j.ejphar.2005.10.049 Access: Primary PubMed abstract.
Complete structured claim and evidenceAdding 10-gingerol suppressed RNP-immune-complex-induced NET formation by human neutrophils.
Experimental context and source evidence
- dose
- Individual gingerols 10 micromolar with RNP/anti-RNP immune complexes 10 micrograms/mL
- duration
- 3 h
- evidence_access
- Primary open full text, results, figure legends and methods, plus PubMed metadata.
- evidence_scope
- literature_reviewed; model-specific source-derived curation, not universally established human effects
- experimental_model
- Neutrophils isolated from healthy human donors
- limitations
- Selected disease-relevant stimulus in isolated cells; not established treatment of lupus or antiphospholipid syndrome.
- nutrient_topic
- Gingerols collection; each molecular form and experimental preparation remains explicit. · Gingerols
- organism
- Neutrophils isolated from healthy human donors
- plain_language
- Adding 10-gingerol suppressed RNP-immune-complex-induced NET formation by human neutrophils.
- primary_references
- Antineutrophil properties of natural gingerols in models of lupus. (2021). https://pubmed.ncbi.nlm.nih.gov/33373329/ DOI: 10.1172/jci.insight.138385
- route
- Ex vivo co-incubation
- tissue
- Human neutrophils
Gingerols: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 437–446
Original AI-assisted curation of thirteen primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · Neutrophils isolated from healthy human donors · source_derived_draft · unverified_draft
## gingerols-10-netosis Adding 10-gingerol suppressed RNP-immune-complex-induced NET formation by human neutrophils. Model/species: Neutrophils isolated from healthy human donors Tissue: Human neutrophils Exposure: Individual gingerols 10 micromolar with RNP/anti-RNP immune complexes 10 micrograms/mL Route: Ex vivo co-incubation Duration: 3 h Limits: Selected disease-relevant stimulus in isolated cells; not established treatment of lupus or antiphospholipid syndrome. Primary reference: Antineutrophil properties of natural gingerols in models of lupus. (2021). https://pubmed.ncbi.nlm.nih.gov/33373329/ DOI: 10.1172/jci.insight.138385 Access: Primary open full text, results, figure legends and methods, plus PubMed metadata.
Complete structured claim and evidenceHuman UGT1A9 was a principal contributor to 10-gingerol 5-O-glucuronide formation in the enzyme comparison.
Experimental context and source evidence
- dose
- Individual 6-, 8- or 10-gingerol with UDP-glucuronic acid; exact concentration series not in accessed abstract
- duration
- Not specified in accessed abstract
- evidence_access
- Primary PubMed abstract.
- evidence_scope
- literature_reviewed; model-specific source-derived curation, not universally established human effects
- experimental_model
- Human liver microsomes and expressed human UGT enzymes
- limitations
- UGT2B7 favors but is not exclusive to 4-prime conjugation; UGT1A9 mainly forms 5-O conjugates. Shared UGT substrates do not prove competition in people.
- nutrient_topic
- Gingerols collection; each molecular form and experimental preparation remains explicit. · Gingerols
- organism
- Human liver microsomes and expressed human UGT enzymes
- plain_language
- Human UGT1A9 was a principal contributor to 10-gingerol 5-O-glucuronide formation in the enzyme comparison.
- primary_references
- Regioselective glucuronidation of gingerols by human liver microsomes and expressed UDP-glucuronosyltransferase enzymes: reaction kinetics and activity correlation analyses for UGT1A9 and UGT2B7. (2015). https://pubmed.ncbi.nlm.nih.gov/25496264/ DOI: 10.1111/jphp.12351
- route
- In vitro incubation
- tissue
- Hepatic and recombinant enzyme preparations
Gingerols: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 338–347
Original AI-assisted curation of thirteen primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · Human liver microsomes and expressed human UGT enzymes · source_derived_draft · unverified_draft
## gingerols-10-ugt1a9 Human UGT1A9 was a principal contributor to 10-gingerol 5-O-glucuronide formation in the enzyme comparison. Model/species: Human liver microsomes and expressed human UGT enzymes Tissue: Hepatic and recombinant enzyme preparations Exposure: Individual 6-, 8- or 10-gingerol with UDP-glucuronic acid; exact concentration series not in accessed abstract Route: In vitro incubation Duration: Not specified in accessed abstract Limits: UGT2B7 favors but is not exclusive to 4-prime conjugation; UGT1A9 mainly forms 5-O conjugates. Shared UGT substrates do not prove competition in people. Primary reference: Regioselective glucuronidation of gingerols by human liver microsomes and expressed UDP-glucuronosyltransferase enzymes: reaction kinetics and activity correlation analyses for UGT1A9 and UGT2B7. (2015). https://pubmed.ncbi.nlm.nih.gov/25496264/ DOI: 10.1111/jphp.12351 Access: Primary PubMed abstract.
Complete structured claim and evidenceHuman UGT2B7 was a principal contributor to 10-gingerol 4-prime-O-glucuronide formation in the enzyme comparison.
Experimental context and source evidence
- dose
- Individual 6-, 8- or 10-gingerol with UDP-glucuronic acid; exact concentration series not in accessed abstract
- duration
- Not specified in accessed abstract
- evidence_access
- Primary PubMed abstract.
- evidence_scope
- literature_reviewed; model-specific source-derived curation, not universally established human effects
- experimental_model
- Human liver microsomes and expressed human UGT enzymes
- limitations
- UGT2B7 favors but is not exclusive to 4-prime conjugation; UGT1A9 mainly forms 5-O conjugates. Shared UGT substrates do not prove competition in people.
- nutrient_topic
- Gingerols collection; each molecular form and experimental preparation remains explicit. · Gingerols
- organism
- Human liver microsomes and expressed human UGT enzymes
- plain_language
- Human UGT2B7 was a principal contributor to 10-gingerol 4-prime-O-glucuronide formation in the enzyme comparison.
- primary_references
- Regioselective glucuronidation of gingerols by human liver microsomes and expressed UDP-glucuronosyltransferase enzymes: reaction kinetics and activity correlation analyses for UGT1A9 and UGT2B7. (2015). https://pubmed.ncbi.nlm.nih.gov/25496264/ DOI: 10.1111/jphp.12351
- route
- In vitro incubation
- tissue
- Hepatic and recombinant enzyme preparations
Gingerols: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 327–336
Original AI-assisted curation of thirteen primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · Human liver microsomes and expressed human UGT enzymes · source_derived_draft · unverified_draft
## gingerols-10-ugt2b7 Human UGT2B7 was a principal contributor to 10-gingerol 4-prime-O-glucuronide formation in the enzyme comparison. Model/species: Human liver microsomes and expressed human UGT enzymes Tissue: Hepatic and recombinant enzyme preparations Exposure: Individual 6-, 8- or 10-gingerol with UDP-glucuronic acid; exact concentration series not in accessed abstract Route: In vitro incubation Duration: Not specified in accessed abstract Limits: UGT2B7 favors but is not exclusive to 4-prime conjugation; UGT1A9 mainly forms 5-O conjugates. Shared UGT substrates do not prove competition in people. Primary reference: Regioselective glucuronidation of gingerols by human liver microsomes and expressed UDP-glucuronosyltransferase enzymes: reaction kinetics and activity correlation analyses for UGT1A9 and UGT2B7. (2015). https://pubmed.ncbi.nlm.nih.gov/25496264/ DOI: 10.1111/jphp.12351 Access: Primary PubMed abstract.
Complete structured claim and evidence
Where it participates (unsigned role)
Free 10-gingerol peaked at 9.5 +/- 2.2 ng/mL approximately one hour after ginger extract ingestion.
Experimental context and source evidence
- dose
- Ginger extract 2 g; LC-MS/MS lower quantification limit 2-5 ng/mL
- duration
- Sampling 0.25-24 h for parent analytes
- evidence_access
- Primary PubMed abstract.
- evidence_scope
- literature_reviewed; model-specific source-derived curation, not universally established human effects
- experimental_model
- Healthy human volunteers
- limitations
- Food/product and analytical sensitivity differ from the 2008 study. Non-detection is not proof of zero absorption.
- nutrient_topic
- Gingerols collection; each molecular form and experimental preparation remains explicit. · Gingerols
- organism
- Healthy human volunteers
- plain_language
- Free 10-gingerol peaked at 9.5 +/- 2.2 ng/mL approximately one hour after ginger extract ingestion.
- primary_references
- Examination of the pharmacokinetics of active ingredients of ginger in humans. (2011). https://pubmed.ncbi.nlm.nih.gov/21638149/ DOI: 10.1208/s12248-011-9286-5
- route
- Oral mixed ginger extract
- tissue
- Plasma
Gingerols: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 404–413
Original AI-assisted curation of thirteen primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · Healthy human volunteers · source_derived_draft · unverified_draft
## gingerols-10-human-free Free 10-gingerol peaked at 9.5 +/- 2.2 ng/mL approximately one hour after ginger extract ingestion. Model/species: Healthy human volunteers Tissue: Plasma Exposure: Ginger extract 2 g; LC-MS/MS lower quantification limit 2-5 ng/mL Route: Oral mixed ginger extract Duration: Sampling 0.25-24 h for parent analytes Limits: Food/product and analytical sensitivity differ from the 2008 study. Non-detection is not proof of zero absorption. Primary reference: Examination of the pharmacokinetics of active ingredients of ginger in humans. (2011). https://pubmed.ncbi.nlm.nih.gov/21638149/ DOI: 10.1208/s12248-011-9286-5 Access: Primary PubMed abstract.
Complete structured claim and evidenceAfter oral ginger, plasma 10-gingerol glucuronides were detected through enzymatic hydrolysis; unconjugated 10-gingerol was not detected in this study.
Experimental context and source evidence
- dose
- Single ginger-product dose 100 mg to 2 g
- duration
- Blood sampling 15 min to 72 h
- evidence_access
- Primary PubMed abstract.
- evidence_scope
- literature_reviewed; model-specific source-derived curation, not universally established human effects
- experimental_model
- 27 healthy human volunteers
- limitations
- Conjugates assessed after hydrolysis; measured total/conjugated exposure is not free parent concentration or tissue target engagement.
- nutrient_topic
- Gingerols collection; each molecular form and experimental preparation remains explicit. · Gingerols
- organism
- 27 healthy human volunteers
- plain_language
- After oral ginger, plasma 10-gingerol glucuronides were detected through enzymatic hydrolysis; unconjugated 10-gingerol was not detected in this study.
- primary_references
- Pharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol and conjugate metabolites in healthy human subjects. (2008). https://pubmed.ncbi.nlm.nih.gov/18708382/ DOI: 10.1158/1055-9965.EPI-07-2934
- route
- Oral mixed ginger product
- tissue
- Plasma
Gingerols: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 371–380
Original AI-assisted curation of thirteen primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · 27 healthy human volunteers · source_derived_draft · unverified_draft
## gingerols-10-human-glucuronides After oral ginger, plasma 10-gingerol glucuronides were detected through enzymatic hydrolysis; unconjugated 10-gingerol was not detected in this study. Model/species: 27 healthy human volunteers Tissue: Plasma Exposure: Single ginger-product dose 100 mg to 2 g Route: Oral mixed ginger product Duration: Blood sampling 15 min to 72 h Limits: Conjugates assessed after hydrolysis; measured total/conjugated exposure is not free parent concentration or tissue target engagement. Primary reference: Pharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol and conjugate metabolites in healthy human subjects. (2008). https://pubmed.ncbi.nlm.nih.gov/18708382/ DOI: 10.1158/1055-9965.EPI-07-2934 Access: Primary PubMed abstract.
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.